LCTX vs CEPV
Comparison between Lineage Cell Therapeutics Inc (LCTX, Company) and Cantor Equity Partners V Inc - Class A (CEPV, Company).
LCTX is from the Healthcare sector, while CEPV is from the Financial Services sector.
LCTX vs CEPV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LCTX vs CEPV - Historical Returns
Returns include dividend reinvestment.
LCTX vs CEPV - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | LCTX | CEPV |
|---|---|---|
| 2026 | -21.65% | +0.39% |
| 2025 | +224.27% | -0.49% |
| 2024 | -53.90% | N/A |
| 2023 | -11.38% | N/A |
| 2022 | -52.82% | N/A |
| 2021 | +26.94% | N/A |
| 2020 | +102.30% | N/A |
| 2019 | -14.42% | N/A |
| 2018 | -54.43% | N/A |
| 2017 | -40.93% | N/A |
| 2016 | -1.90% | N/A |
| 2015 | +4.06% | N/A |
| 2014 | +2.47% | N/A |
| 2013 | +8.76% | N/A |
| 2012 | -48.69% | N/A |
| 2011 | -34.87% | N/A |
| 2010 | +76.11% | N/A |
| 2009 | +141.72% | N/A |
| 2008 | +365.80% | N/A |
| 2007 | +57.72% | N/A |
| 2006 | -17.19% | N/A |
| 2005 | -79.47% | N/A |
| 2004 | +4.86% | N/A |
| 2003 | -15.34% | N/A |
| 2002 | -66.52% | N/A |
| 2001 | -42.50% | N/A |
| 2000 | -16.67% | N/A |
| 1999 | +3.64% | N/A |
LCTX vs CEPV Drawdown Comparison
The maximum drawdown for LCTX was -98.99%, occurring on Aug 28, 2006. This drawdown has not yet recovered.
The maximum drawdown for CEPV was -2.61%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current LCTX drawdown is -90.40%. The current CEPV drawdown is -0.29%.
| Rank | LCTX | CEPV |
|---|---|---|
| #1 | -98.99% Feb 24, 2000 - Aug 28, 2006 | -2.61% Jan 15, 2026 - Mar 27, 2026 |
| #2 | -30.10% Nov 8, 1999 - Jan 26, 2000 | -1.45% Nov 5, 2025 - Jan 15, 2026 |
| #3 | -15.38% Jan 26, 2000 - Feb 18, 2000 | N/A |
| #4 | -3.66% Nov 1, 1999 - Nov 3, 1999 | N/A |
Correlation
Correlation between LCTX and CEPV is -0.62 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks